DAB2
Disabled homolog 2
Also known as: DAB2_HUMAN, DOC-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P98082
- Gene
- DAB2
- Ensembl
- ENSG00000153071
- Chromosome
- 5
- Canonical length
- 770 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli fibrillar center,Vesicles,Plasma membrane
OverviewNCBI Gene
This gene encodes a mitogen-responsive phosphoprotein. It is expressed in normal ovarian epithelial cells, but is down-regulated or absent from ovarian carcinoma cell lines, suggesting its role as a tumor suppressor. This protein binds to the SH3 domains of GRB2, an adaptor protein that couples tyrosine kinase receptors to SOS (a guanine nucleotide exchange factor for Ras), via its C-terminal proline-rich sequences, and may thus modulate growth factor/Ras pathways by competing with SOS for binding to GRB2. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
770 residues, UniProt reviewed canonical sequence.
>P98082|DAB2
1 MSNEVETSAT NGQPDQQAAP KAPSKKEKKK GPEKTDEYLL ARFKGDGVKY KAKLIGIDDV
61 PDARGDKMSQ DSMMKLKGMA AAGRSQGQHK QRIWVNISLS GIKIIDEKTG VIEHEHPVNK
121 ISFIARDVTD NRAFGYVCGG EGQHQFFAIK TGQQAEPLVV DLKDLFQVIY NVKKKEEEKK
181 KIEEASKAVE NGSEALMILD DQTNKLKSGV DQMDLFGDMS TPPDLNSPTE SKDILLVDLN
241 SEIDTNQNSL RENPFLTNGI TSCSLPRPTP QASFLPENAF SANLNFFPTP NPDPFRDDPF
301 TQPDQSTPSS FDSLKSPDQK KENSSSSSTP LSNGPLNGDV DYFGQQFDQI SNRTGKQEAQ
361 AGPWPFSSSQ TQPAVRTQNG VSEREQNGFS VKSSPNPFVG SPPKGLSIQN GVKQDLESSV
421 QSSPHDSIAI IPPPQSTKPG RGRRTAKSSA NDLLASDIFA PPVSEPSGQA SPTGQPTALQ
481 PNPLDLFKTS APAPVGPLVG LGGVTVTLPQ AGPWNTASLV FNQSPSMAPG AMMGGQPSGF
541 SQPVIFGTSP AVSGWNQPSP FAASTPPPVP VVWGPSASVA PNAWSTTSPL GNPFQSNIFP
601 APAVSTQPPS MHSSLLVTPP QPPPRAGPPK DISSDAFTAL DPLGDKEIKD VKEMFKDFQL
661 RQPPAVPARK GEQTSSGTLS AFASYFNSKV GIPQENADHD DFDANQLLNK INEPPKPAPR
721 QVSLPVTKST DNAFENPFFK DSFGSSQASV ASSQPVSSEM YRDPFGNPFALocalizationUniProt · AlphaFold · HPA
Whether an antibody against DAB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 213 nTPM
Expression across tissuesHPA
Tissue
- placenta: 213 nTPM
- kidney: 167 nTPM
- epididymis: 110 nTPM
- adrenal gland: 107 nTPM
- adipose tissue: 74 nTPM
- spleen: 55 nTPM
Single-cell type
- hofbauer cells: 1,696 nCPM
- syncytiotrophoblasts: 942 nCPM
- platelets: 847 nCPM
- epididymal efferent duct absorptive cells: 453 nCPM
- epididymal principal cells: 305 nCPM
- breast lactating cells: 200 nCPM
Immune cell
- plasmacytoid DC: 49 nTPM
- total PBMC: 13 nTPM
- myeloid DC: 6.3 nTPM
- basophil: 5.9 nTPM
- intermediate monocyte: 4.6 nTPM
- neutrophil: 3.2 nTPM
Brain region
- choroid plexus: 65 nTPM
- thalamus: 53 nTPM
- medulla oblongata: 41 nTPM
- cerebellum: 36 nTPM
- pons: 34 nTPM
- white matter: 32 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.41
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cellular response to epidermal growth factor stimulus
- clathrin coat assembly
- leading edge cell differentiation
- negative regulation of androgen receptor signaling pathway
- negative regulation of apoptotic process
- negative regulation of canonical Wnt signaling pathway
- negative regulation of cell growth
- negative regulation of epithelial cell proliferation
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of neuron projection development
- negative regulation of protein localization to plasma membrane
- negative regulation of transcription by RNA polymerase II
- positive regulation of aldosterone biosynthetic process
- positive regulation of aldosterone secretion
- positive regulation of cell migration
- positive regulation of clathrin-dependent endocytosis
- positive regulation of early endosome to late endosome transport
- positive regulation of endocytosis
- positive regulation of epithelial to mesenchymal transition
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- positive regulation of SMAD protein signal transduction
- positive regulation of substrate adhesion-dependent cell spreading
- positive regulation of transcription by RNA polymerase II
- positive regulation of Wnt signaling pathway, planar cell polarity pathway
- protein transport
- receptor-mediated endocytosis
- response to salt
- response to steroid hormone
- transforming growth factor beta receptor signaling pathway
- Wnt signaling pathway
Molecular functions
- cargo receptor activity
- clathrin adaptor activity
- low-density lipoprotein particle receptor binding
- SMAD binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DAB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DAB2 as an antibody target. Whether an autoantibody or antibody against DAB2 could matter depends on whether native DAB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DAB2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DAB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...